Oligoprogressive

specific

Disease progression at a limited number of anatomic sites, in the context of stable disease at other anatomic sites.

Centers

Active Trials

—

Cancer Funding

Top Centers for Oligoprogressive(8)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	—	56.2
2	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive	—	—	56.2
3	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive	—	—	56.2
4	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive	—	—	56.2
5	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	—	56.2
6	University of Illinois Cancer CenterChicago, IL	—	—	56.2
7	Boston University Cancer CenterBoston, MA	—	—	56.2
8	Cancer Center at IllinoisUrbana, IL	—	—	56.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →